SCHEMBL8669802

SCHEMBL8669802

O=[N+]([O-])c1cccc([CH]Cc2cccc([N+](=O)[O-])c2)c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.57
NFE2L2 Q16236 3/20 0.56
FBP1 P09467 2/20 0.54
VCP P55072 1/20 0.54
CYP19A1 P11511 1/20 0.54
LMNA P02545 2/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ALDH1A1 P00352 2/20 0.49
GLO1 Q04760 1/20 0.49
NPC1 O15118 2/20 0.48
HSP90AA1 P07900 1/20 0.48
CYP1A2 P05177 2/20 0.47
MAPT P10636 2/20 0.47
METAP1 P53582 1/20 0.47
RAB9A P51151 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6328580 0.92 NFE2L2 (0.58) TSHRNFE2L2FBP1VCPCYP19A1
SCHEMBL12470562 0.90 ALDH1A1 (0.58) TSHRNFE2L2FBP1VCPCYP19A1
SCHEMBL6376999 0.89 CYP19A1 (0.61) TSHRNFE2L2FBP1VCPCYP19A1
SCHEMBL287236 0.82 TSHR (0.65) TSHRNFE2L2LMNAMEN1KMT2A
SCHEMBL3718150 0.81 TSHR (0.62) TSHRNFE2L2LMNAMEN1KMT2A
SCHEMBL7137045 0.81 NFE2L2 (0.61) TSHRNFE2L2FBP1VCPCYP19A1
SCHEMBL2406215 0.80 NFE2L2 (0.51) TSHRNFE2L2FBP1VCPCYP19A1
SCHEMBL28879992 0.79 TSHR (0.61) TSHRNFE2L2LMNAMEN1KMT2A
SCHEMBL7077091 0.79 TSHR (0.61) TSHRNFE2L2LMNAMEN1KMT2A
SCHEMBL10678503 0.79 NFE2L2 (0.59) TSHRNFE2L2FBP1VCPCYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811422-A USEFUL FOR TREATING VIRAL INFECTIONS THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1998-09-22 US disclosed
US-5610294-A VIRAL TREATMENT THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1997-03-11 US disclosed
US-5506355-A REACTING DIAMINE HAVING DIOL PROTECTED WITH CYCLIC ACETAL GROUP IN SOLVENT WITH HINDERED AMINE BASE AND SULFONYL GROUP PRECURSOR, ALKYLATING IN PRESENCE OF BASE THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-04-09 US disclosed